Skip to content

Patient Education in Gastroesophageal Reflux Disease

Patient Education in Gastroesophageal Reflux Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00618150
Enrollment
211
Registered
2008-02-18
Start date
1996-09-30
Completion date
Unknown
Last updated
2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

GERD, Dyspepsia, Education, Information

Brief summary

Patients with gastroesophageal reflux disease (heart-burn, acid regurgitation)may benefit from an educational program explaining the medical aspects of the disease, self-management strategies and how to deal with health services. We hypothesized that patients having participated in an educational program would experience an improved quality of life when compared to patients who did not take part (controls).

Interventions

BEHAVIORALPatient education

An educational program: Three lessons spaced over 2 weeks.

Sponsors

Norwegian Foundation for Health and Rehabilitation
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* heartburn and acid regurgitation the dominant symptom * needing relief at least 5 days/ week when symptoms were at their worst * disease history at least 3 months * ability to give informed consent

Exclusion criteria

* current or previous esophagitis stage 2(Savary-Miller) or greater or peptic ulc * continuous need of proton pump inhibitors or NSAIDs * wish for surgical treatment * earlier surgical treatment in the GI-tract * pregnancy * alcohol or drug abuse

Design outcomes

Primary

MeasureTime frame
Quality of lifeone year

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026